Abstract

This IDC Survey Spotlight analyzes how life sciences organizations in Europe are making technology investments to enable collaboration with the broader ecosystem of stakeholders and leverage the potential of intelligent ecosystems to support core business priorities, accelerate innovation, and empower long-term resilience.

The analysis is based on the life sciences sample of IDC's European Healthcare and Life Sciences Insights Survey, 2022. The sample analyzed in this study covers pharmaceutical organizations, medical device manufacturers, and clinical research organizations across 14 European countries.

Coverage